TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ASND

Ascendis Pharma AS

Healthcare · Biotechnology

230.10$ +2.0% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for Ascendis Pharma AS (ASND): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/11/2026.

Next report 11/11/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 23 · -28.0 % 23 Q4 23 · 12.5 % 23 Q1 24 · -62.0 % 24 Q2 24 · -44.5 % 24 Q3 24 · -17.8 % 24 Q4 24 · 45.3 % 24 Q1 25 · -4.6 % 25 Q2 25 · 34.5 % 25 Q3 25 · -733.3 % 25 Q4 25 · -129.2 % 25 Q1 26 · -37.2 % 26 Q2 26 · 321.8 % 26

EPS estimate beaten

Full history 17 of 45 quarters (38%)
Last 16 quarters 6 of 16 quarters (38%)

Earnings Call Transcripts

Search all transcripts →

  • 08/13/2026 Earnings Call Q2 2026 Open →
  • 05/07/2026 Earnings Call Q1 2026 Open →
  • 02/11/2026 Earnings Call Q4 2025 Open →
  • 11/12/2025 Earnings Call Q3 2025 Open →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?